Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies

The Lancet Gastroenterology and Hepatology

Volumn 1, Issue 1, 2016, Pages 45-55

  Xiao, Amy Y ^a   Tan, Marianne L Y ^a   Wu, Landy M ^a   Asrani, Varsha M ^a   Windsor, John A ^a   Yadav, Dhiraj ^b   Petrov, Maxim S ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PANCREATITIS; ARTICLE; BIOLOGICAL ACCIDENT; CHRONIC PANCREATITIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; META ANALYSIS (TOPIC); MORTALITY RATE; PANCREAS CANCER; PANCREAS CYST; PANCREAS DISEASE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SYSTEMATIC REVIEW (TOPIC); COHORT ANALYSIS; GLOBAL HEALTH; INCIDENCE; META ANALYSIS; MORTALITY; STATISTICS AND NUMERICAL DATA;

COHORT STUDIES; GLOBAL HEALTH; HUMANS; INCIDENCE; PANCREATIC DISEASES; REGRESSION ANALYSIS;

EID: 84995931735     PISSN: 24681253     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2468-1253(16)30004-8     Document Type: Article

References (78)

1. 1 Hall, TC, Garcea, G, Webb, MA, Al-Leswas, D, Metcalfe, MS, Dennison, AR, The socio-economic impact of chronic pancreatitis: a systematic review. J Eval Clin Pract 20 (2014), 203–207.
2. 2 Fagenholz, PJ, Castillo, CF, Harris, NS, Pelletier, AJ, Camargo, CA Jr, Increasing United States hospital admissions for acute pancreatitis, 1988–2003. Ann Epidemiol 17 (2007), 491–497.
3. 3 Yang, CJ, Chen, J, Phillips, AR, Windsor, JA, Petrov, MS, Predictors of severe and critical acute pancreatitis: a systematic review. Dig Liver Dis 46 (2014), 446–451.
4. 4 Das, SL, Singh, PP, Phillips, AR, Murphy, R, Windsor, JA, Petrov, MS, Newly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis. Gut 63 (2014), 818–831.
5. 5 Sankaran, SJ, Xiao, AY, Wu, LM, Windsor, JA, Forsmark, CE, Petrov, MS, Frequency of progression from acute to chronic pancreatitis and risk factors: a meta-analysis. Gastroenterology 149 (2015), 1490–1500.
6. 6 Malka, D, Hammel, P, Maire, F, et al. Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 51 (2002), 849–852.
7. 7 Vidarsdottir, H, Moller, PH, Vidarsdottir, H, Thorarinsdottir, H, Bjornsson, ES, Acute pancreatitis: a prospective study on incidence, etiology, and outcome. Eur J Gastroenterol Hepatol 25 (2013), 1068–1075.
8. 8 Banks, PA, Conwell, DL, Toskes, PP, The management of acute and chronic pancreatitis. Gastroenterol Hepatol 6:suppl 5 (2010), 1–16.
9. 9 Alsamarrai, A, Das, SL, Windsor, JA, Petrov, MS, Factors that affect risk for pancreatic disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol 12 (2014), 1635–1644.
10. 10 Petrov, MS, Abdominal fat: a key player in metabolic acute pancreatitis. Am J Gastroenterol 108 (2013), 140–142.
11. 11 Pannucci, CJ, Wilkins, EG, Identifying and avoiding bias in research. Plast Reconstr Surg 126 (2010), 619–625.
12. 12 Wells, G, Shea, B, O'Connell, D, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed Jan 7, 2016).
13. 13 WHO. Definition of region groupings. http://www.who.int/healthinfo/global_burden_disease/definition_regions/en/, 2015 (accessed May 29, 2016).
14. 14 Knapp, G, Hartung, J, Improved tests for a random effects meta-regression with a single covariate. Stat Med 22 (2003), 2693–2710.
15. 15 DerSimonian, R, Laird, N, Meta-analysis in clinical trials. Control Clin Trials 7 (1986), 177–188.
16. 16 Egger, M, Smith, GD, Schneider, M, Minder, C, Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997), 629–634.
17. 17 Akiba, S, Hirayama, T, Cigarette smoking and cancer mortality risk in Japanese men and women—results from reanalysis of the six-prefecture cohort study data. Environ Health Perspect 87 (1990), 19–26.
18. 18 Levi, F, Randimbison, L, Te, VC, Franceschi, S, La Vecchia, C, Trends in survival for patients diagnosed with cancer in Vaud, Switzerland, between 1974 and 1993. Ann Oncol 11 (2000), 957–963.
19. 19 Brenner, H, Soderman, B, Hakulinen, T, Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland. Int J Epidemiol 31 (2002), 456–462.
20. 20 Inoue, M, Tajima, K, Takezaki, T, et al. Epidemiology of pancreatic cancer in Japan: a nested case-control study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Int J Epidemiol 32 (2003), 257–262.
21. 21 Yeole, BB, Kumar, AV, Population-based survival from cancers having a poor prognosis in Mumbai (Bombay), India. Asian Pac J Cancer Prev 5 (2004), 175–182.
22. 22 Crocetti, E, Capocaccia, R, Casella, C, et al. Population-based incidence and mortality cancer trends (1986–1997) from the network of Italian cancer registries. Eur J Cancer Prev 13 (2004), 287–295.
23. 23 Parks, RW, Bettschart, V, Frame, S, Stockton, DL, Brewster, DH, Garden, OJ, Benefits of specialisation in the management of pancreatic cancer: results of a Scottish population-based study. Br J Cancer 91 (2004), 459–465.
24. 24 Navarro Silvera, SA, Miller, AB, Rohan, TE, Hormonal and reproductive factors and pancreatic cancer risk: a prospective cohort study. Pancreas 30 (2005), 369–374.
25. 25 Vaktskjold, A, Lebedintseva, JA, Korotov, DS, Tkatsjov, AV, Podjakova, TS, Lund, E, Cancer incidence in Arkhangelskaja Oblast in northwestern Russia. The Arkhangelsk Cancer Registry. BMC Cancer, 5, 2005, 82.
26. 26 Rapp, K, Schroeder, J, Klenk, J, et al. Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer 93 (2005), 1062–1067.
27. 27 Ahlgren, M, Wohlfahrt, J, Olsen, LW, Sorensen, TI, Melbye, M, Birth weight and risk of cancer. Cancer 110 (2007), 412–419.
28. 28 Altieri, A, Hemminki, K, Number of siblings and the risk of solid tumours: a nation-wide study. Br J Cancer 96 (2007), 1755–1759.
29. 29 Heuch, I, Jacobsen, BK, Albrektsen, G, Kvåle, G, Reproductive factors and pancreatic cancer risk: a Norwegian cohort study. Br J Cancer 98 (2008), 189–193.
30. 30 Mohebbi, M, Mahmoodi, M, Wolfe, R, et al. Geographical spread of gastrointestinal tract cancer incidence in the Caspian Sea region of Iran: spatial analysis of cancer registry data. BMC Cancer, 8, 2008, 137.
31. 31 Lefebvre, AC, Maurel, J, Boutreux, S, et al. Pancreatic cancer: incidence, treatment and survival trends—1175 cases in Calvados (France) from 1978 to 2002. Gastroenterol Clin Biol 33 (2009), 1045–1051.
32. 32 Stolzenberg-Solomon, RZ, Jacobs, EJ, Arslan, AA, et al. Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: cohort consortium vitamin D pooling project of rarer cancers. Am J Epidemiol 172 (2010), 81–93.
33. 33 Chang, CC, Chiu, HF, Yang, CY, Parity, age at first birth, and risk of death from pancreatic cancer: evidence from a cohort in Taiwan. Pancreas 39 (2010), 567–571.
34. 34 Bouvier, AM, David, M, Jooste, V, Chauvenet, M, Lepage, C, Faivre, J, Rising incidence of pancreatic cancer in France. Pancreas 39 (2010), 1243–1246.
35. 35 Gapstur, SM, Jacobs, EJ, Deka, A, McCullough, ML, Patel, AV, Thun, MJ, Association of alcohol intake with pancreatic cancer mortality in never smokers. Arch Int Med 171 (2011), 444–451.
36. 36 Cronin-Fenton, DP, Erichsen, R, Mortensen, FV, Dikinis, S, Nørgaard, M, Jacobsen, J, Pancreatic cancer survival in central and northern Denmark from 1998 through 2009: a population-based cohort study. Clin Epidemiol 3:suppl 1 (2011), 19–25.
37. 37 Masoompour, SM, Yarmohammadi, H, Rezaianzadeh, A, Lankarani, KB, Cancer incidence in southern Iran, 1998–2002: results of population-based cancer registry. Cancer Epidemiol 35 (2011), e42–e47.
38. 38 Chen, WQ, Zeng, HM, Zheng, RS, Zhang, SW, He, J, Cancer incidence and mortality in China, 2007. Chin J Cancer Res 24 (2012), 1–8.
39. 39 Chen, WQ, Zheng, RS, Zhang, SW, et al. Report of incidence and mortality in china cancer registries, 2008. Chin J Cancer Res 24 (2012), 171–180.
40. 40 Nechuta, S, Shu, XO, Li, HL, et al. Prospective cohort study of tea consumption and risk of digestive system cancers: results from the Shanghai Women's Health Study. Am J Clin Nutr 96 (2012), 1056–1063.
41. 41 Heinen, MM, Verhage, BA, Goldbohm, RA, van den Brandt, PA, Intake of vegetables, fruits, carotenoids and vitamins C and E and pancreatic cancer risk in The Netherlands Cohort Study. Int J Cancer 130 (2012), 147–158.
42. 42 Hippisley-Cox, J, Coupland, C, Symptoms and risk factors to identify women with suspected cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract 63 (2013), e11–e21.
43. 43 Hippisley-Cox, J, Coupland, C, Symptoms and risk factors to identify men with suspected cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract 63 (2013), e1–10.
44. 44 Thomassen, I, van Gestel, YR, Lemmens, VE, de Hingh, IH, Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin. Dis Colon Rectum 56 (2013), 1373–1380.
45. 45 Chen, W, Zheng, R, Zhang, S, et al. Report of incidence and mortality in China cancer registries, 2009. Chin J Cancer Res 25 (2013), 10–21.
46. 46 Lin, Y, Fu, R, Grant, E, et al. Association of body mass index and risk of death from pancreas cancer in Asians: findings from the Asia Cohort Consortium. Eur J Cancer Prev 22 (2013), 244–250.
47. 47 Lin, Y, Yagyu, K, Ueda, J, Kurosawa, M, Tamakoshi, A, Kikuchi, S, Active and passive smoking and risk of death from pancreatic cancer: findings from the Japan Collaborative Cohort Study. Pancreatology 13 (2013), 279–284.
48. 48 Musicco, M, Adorni, F, Di Santo, S, et al. Inverse occurrence of cancer and Alzheimer disease: a population-based incidence study. Neurology 81 (2013), 322–328.
49. 49 Tazi, MA, Er-Raki, A, Benjaafar, N, Cancer incidence in Rabat, Morocco: 2006–2008. Ecancermedicalscience, 7, 2013, 338.
50. 50 Untawale, S, Odegaard, AO, Koh, WP, Jin, AZ, Yuan, JM, Anderson, KE, Body mass index and risk of pancreatic cancer in a Chinese population. PLoS One, 9, 2014, e85149.
51. 51 Innos, K, Baburin, A, Aareleid, T, Cancer patient survival in Estonia 1995–2009: time trends and data quality. Cancer Epidemiol 38 (2014), 253–258.
52. 52 Ekbom, A, McLaughlin, JK, Karlsson, BM, et al. Pancreatitis and pancreatic cancer: a population-based study. J Natl Cancer Inst 86 (1994), 625–627.
53. 53 Floyd, A, Pedersen, L, Nielsen, GL, Thorladcius-Ussing, O, Sorensen, HT, Secular trends in incidence and 30-day case fatality of acute pancreatitis in North Jutland County, Denmark: a register-based study from 1981–2000. Scand J Gastroenterol 37 (2002), 1461–1465.
54. 54 Lindkvist, B, Appelros, S, Manjer, J, Borgstrom, A, Trends in incidence of acute pancreatitis in a Swedish population: is there really an increase?. Clin Gastroenterol Hepatol 2 (2004), 831–837.
55. 55 Blomgren, KJ, Sundstrom, A, Steineck, G, Wiholm, BE, Interviewer variability—quality aspects in a case-control study. Eur J Epidemiol 21 (2006), 267–277.
56. 56 Nojgaard, C, Prognosis of acute and chronic pancreatitis—a 30-year follow-up of a Danish cohort. Dan Med Bull, 57, 2010, B4228.
57. 57 Shen, HN, Lu, CL, Incidence, resource use, and outcome of acute pancreatitis with/without intensive care: a nationwide population-based study in Taiwan. Pancreas 40 (2011), 10–15.
58. 58 Chung, SD, Chen, KY, Xirasagar, S, Tsai, MC, Lin, HC, More than 9-times increased risk for pancreatic cancer among patients with acute pancreatitis in Chinese population. Pancreas 41 (2012), 142–146.
59. 59 Sadr-Azodi, O, Andren-Sandberg, A, Orsini, N, Wolk, A, Cigarette smoking, smoking cessation and acute pancreatitis: a prospective population-based study. Gut 61 (2012), 262–267.
60. 60 Yadav, D, O'Connell, M, Papachristou, GI, Natural history following the first attack of acute pancreatitis. Am J Gastroenterol 107 (2012), 1096–1103.
61. 61 Roberts, SE, Thorne, K, Evans, PA, Akbari, A, Samuel, DG, Williams, JG, Mortality following acute pancreatitis: social deprivation, hospital size and time of admission: record linkage study. BMC Gastroenterol, 14, 2014, 153.
62. 62 Schmidt, DN, Apparent risk factors for chronic and acute pancreatitis in Stockholm county. Spirits but not wine and beer. Int J Pancreatol 8 (1991), 45–50.
63. 63 Nojgaard, C, Bendtsen, F, Becker, U, Andersen, JR, Holst, C, Matzen, P, Danish patients with chronic pancreatitis have a four-fold higher mortality rate than the Danish population. Clin Gastroenterol Hepatol 8 (2010), 384–390.
64. 64 Yadav, D, Muddana, V, O'Connell, M, Hospitalizations for chronic pancreatitis in Allegheny County, Pennsylvania, USA. Pancreatology 11 (2011), 546–552.
65. 65 Verhage, BA, Schouten, LJ, Goldbohm, RA, van den Brandt, PA, Anthropometry and pancreatic cancer risk: an illustration of the importance of microscopic verification. Cancer Epidemiol Biomarkers Prev 16 (2007), 1449–1454.
66. 66 Yadav, D, Lowenfels, AB, The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 144 (2013), 1252–1261.
67. 67 WHO. Data sources and methods: Lyon, France. http://globocan.iarc.fr/Pages/DataSource_and_methods.aspx, 2012 (accessed May 29, 2016).
68. 68 Konner, J, O'Reilly, E, Pancreatic cancer: epidemiology, genetics, and approaches to screening. Oncology (Williston Park) 16 (2002), 1615–1622.
69. 69 Lowenfels, AB, Maisonneuve, P, Epidemiology and prevention of pancreatic cancer. Jpn J Clin Oncol 34 (2004), 238–244.
70. 70 Sanchez, GV, Weinstein, SJ, Stolzenberg-Solomon, RZ, Is dietary fat, vitamin D, or folate associated with pancreatic cancer?. Mol Carcinog 51 (2012), 119–127.
71. 71 Yeo, TP, Hruban, RH, Brody, J, Brune, K, Fitzgerald, S, Yeo, CJ, Assessment of “gene-environment” interaction in cases of familial and sporadic pancreatic cancer. J Gastrointest Surg 13 (2009), 1487–1494.
72. 72 Bosetti, C, Lucenteforte, E, Silverman, DT, et al. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol 23 (2012), 1880–1888.
73. 73 Barreto, SG, Neale, RE, Vitamin D and pancreatic cancer. Cancer Lett 368 (2015), 1–6.
74. 74 Lankisch, PG, Breuer, N, Bruns, A, Weber-Dany, B, Lowenfels, AB, Maisonneuve, P, Natural history of acute pancreatitis: a long-term population-based study. Am J Gastroenterol 104 (2009), 2797–2805.
75. 75 Whitcomb, DC, Genetic risk factors for pancreatic disorders. Gastroenterology 144 (2013), 1292–1302.
76. 76 Murray, CJ, Lopez, AD, Measuring the global burden of disease. N Engl J Med 369 (2013), 448–457.
77. 77 Schweitzer, A, Horn, J, Mikolajczyk, RT, Krause, G, Ott, JJ, Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 386 (2015), 1546–1555.
78. 78 Andersen, DK, Andren-Sandberg, A, Duell, EJ, et al. Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop. Pancreas 42 (2013), 1227–1237.